Latest news
Entera Bio (NASDAQ:ENTX) Slides on Wider Q2 Loss Despite FDA Phase 3 Alignment and $275M Cash Raise - ChartMillChartMill · Fri, 07 Aug 2026 20:41:10 GMTSERV Q2 Loss Wider Than Expected, Revenues Increase Y/Y, Stock Down - Yahoo FinanceYahoo Finance · Fri, 07 Aug 2026 16:41:00 GMTOklo Jumps 7% After Revenue Tops Estimates, Offsetting Wider Loss and Cash Burn Concerns - finance.biggo.comfinance.biggo.com · Fri, 07 Aug 2026 14:35:00 GMTQBTS Stock Falls on Wider-Than-Expected Q2 Loss and Revenue Miss - Zacks Investment ResearchZacks Investment Research · Fri, 07 Aug 2026 14:03:26 GMTOklo shares rise as revenue beat offsets wider Q2 loss - Proactive financial newsProactive financial news · Fri, 07 Aug 2026 10:05:00 GMTVerrica Pharma reports wider-than-expected Q2 adj loss per share - TradingViewTradingView · Thu, 06 Aug 2026 20:29:30 GMTRVMD Posts Wider-Than-Anticipated Loss in Q2, Lifts '26 Expense View - Yahoo FinanceYahoo Finance · Thu, 06 Aug 2026 18:00:00 GMTImmunovant's Q1 Loss Wider Than Expected, Pipeline in Progress - The Globe and MailThe Globe and Mail · Thu, 06 Aug 2026 16:34:00 GMT